Palatin Technologies
PTN
#10273
Rank
A$34.71 M
Marketcap
A$19.51
Share price
-1.75%
Change (1 day)
13,875.67%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -A$7.94 Million

According to Palatin Technologies's latest financial reports the company's current earnings are A$8.84 Million. In 2024 the company made an earning of -A$37.5 Million, an increase over its 2023 earnings that were of -A$45.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$7.94 Million-78.84%
2024 -A$37.5 Million-16.9%
2023 -A$45.12 Million5.99%
2022 -A$42.57 Million-13.7%
2021 -A$49.33 Million33.25%
2020 -A$37.02 Million-172.11%
2019 A$51.33 M2352.33%
2018 A$2.09 M-94.13%
2017 A$35.66 M-154.92%
2016 -A$64.95 Million3.67%
2015 -A$62.65 Million878%
2014 -A$6.41 Million-72.64%
2013 -A$23.42 Million-33.11%
2012 -A$35 Million77.71%
2011 -A$19.7 Million
2003 -A$33.36 Million29.93%
2002 -A$25.67 Million36.18%
2001 -A$18.85 Million
1999 -A$15.65 Million6.04%
1998 -A$14.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.15 B-541,884.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.40 B-305,913.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$1.11 B-16,758.74%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$16.71 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.22 B-3,513.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$0.13 B-2,097.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-A$41.04 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$80.65 Million 1,108.36%๐Ÿ‡บ๐Ÿ‡ธ USA